05:12 PM EDT, 06/26/2025 (MT Newswires) -- Frank Mccormick, Director, on June 24, 2025, sold 100,000 shares in BridgeBio Pharma ( BBIO ) for $4,422,800. Following the Form 4 filing with the SEC, Mccormick has control over a total of 963,254 shares of the company, with 83,275 shares held directly and 879,979 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1743881/000095017025090498/xslF345X05/ownership.xml